Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years

New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.

This development comes after the Subject Expert Committee discussed recommendations for...read more

Comments

Popular posts from this blog

Will have a good time with Modi, says Trump before leaving for Houston

Budget 2019 fails to address real estate sector's most pressing concerns

SC overturns BCCI’s life ban on Sreesanth in IPL spot-fixing case